DOXYMED

What this means for you

Registered since 26 Nov 2024. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

97319456

Registration number

7580578

Mark type

Stylized text

Filed

18 Mar 2022

Published for opposition

19 Dec 2023

Registered

26 Nov 2024

Attorney of record

Ashley D. Johnson

Goods and services

• Class 001 — Chemicals: Pharmaceutical compositions and medicaments for use in the treatment of cancer; Pharmaceutical compositions and medicaments for use in treatment of a disease or condition in a subject, namely, reducing cancer stem cells, reducing tumor initiation, reducing metastatic spread; Pharmaceutical compositions and medicaments for use in treatment of a disease or condition in a subject, namely, increasing cytostatic and cyclotoxic activity of tumor cell lines; Pharmaceutical compositions and medicaments for use in treatment of a disease or condition in a subject, namely, inhibiting the activity of one or more matrix metalloproteinases; compositions and medicaments for use in the treatment of cancer

Owner

• Right2Try Inc., Lewes, DE, US
• Right2Try Inc., Lewes, DE, US
• Right2Try Inc., Lewes, DE, US

Prosecution history

• 26 Nov 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
• 26 Nov 2024 — REGISTERED-PRINCIPAL REGISTER
• 21 Oct 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
• 21 Oct 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
• 29 Sept 2024 — STATEMENT OF USE PROCESSING COMPLETE
• 29 Jul 2024 — USE AMENDMENT FILED
• 29 Sept 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
• 29 Jul 2024 — TEAS STATEMENT OF USE RECEIVED
• 13 Feb 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
• 19 Dec 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 19 Dec 2023 — PUBLISHED FOR OPPOSITION
• 29 Nov 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
• 09 Nov 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 07 Nov 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 06 Nov 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE